Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Successful oral delivery of calcitonin reported by Novartis

Jan. 17, 2000

P&U will market Novo Nordisk's HRT products in U.S.

Jan. 17, 2000

Antiobesity effects of LEP-(116-130) do not involve interaction with leptin receptors

Jan. 14, 2000

Significant progress made in continuing trials of Oralgen/Oralin

Jan. 14, 2000

PDH activators with benzenesulfonamide structure designed at AstraZeneca

Jan. 14, 2000

Genset and Whitehead Institute collaborate on obesity and diabetes research

Jan. 14, 2000

TKT completes pivotal phase III studies of GA-EPO as treatment of renal failure

Jan. 13, 2000

AHP dedicates substantial effort to discovery of PTPase inhibitors

Jan. 13, 2000

Hemosol completes phase II trial of Hemolink in CABG patients

Jan. 13, 2000

KRP-297 improves glucose uptake in skeletal muscle in insulin-resistant mice

Jan. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...